진보람 (Washington University School of Medicine)님 | 한빛사연구자 > 한빛사

Washington University School of Medicine

최종업데이트 2026.01.21.

Beneficial effects of SGLT1/2 and SGLT2 inhibitors on vaso-occlusive events and organ damage in sickle cell disease mice
- Cardiovasc. Res., Jan 14 2026, cvag003 | https://doi.org/10.1093/cvr/cvag003
- 2026-01
- 의약학
- 한빛사논문
Hot melt extrusion-enhanced Angelica gigas alleviates benign prostatic hyperplasia via AR/ERK signaling: A network pharmacology-based mechanistic study
- Phytomedicine, Available online 8 November 2025, 157530 | https://doi.org/10.1016/j.phymed.2025.157530
- 2025-11
- 의약학
- 한빛사논문
Antioxidant mitoquinone suppresses benign prostatic hyperplasia by regulating the AR–NLRP3 pathway
- Redox Biol., Available online 11 July 2023 | https://doi.org/10.1016/j.redox.2023.102816
- 2023-07
- 의약학
- 한빛사논문
Rosmarinic acid suppresses colonic inflammation in dextran sulphate sodium (DSS)-induced mice via dual inhibition of NF-κB and STAT3 activation
- Sci Rep, 2017 Apr 6;7:46252 | doi: 10.1038/srep46252
- 2017-04
- 의약학
- 상위피인용논문
Targeting benign prostate hyperplasia treatments: AR/TGF-β/NOX4 inhibition by apocynin suppresses inflammation and proliferation
- J. Adv. Res., 2023 Apr 14;S2090-1232(23)00112-1 | https://doi.org/10.1016/j.jare.2023.04.00
- 2023-04
- 의약학
- 한빛사논문

연구자 ID

저자논문